Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis
Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole
Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole
View: Text | PDF
Research Article Cell biology Hematology

Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis

  • Text
  • PDF
Abstract

In response to collagen stimulation, platelets use a coordinated system of fluid entry to undergo membrane ballooning, procoagulant spreading, and microvesiculation. We hypothesized that water entry was mediated by the water channel aquaporin-1 (AQP1) and aimed to determine its role in the platelet procoagulant response and thrombosis. We established that human and mouse platelets express AQP1 and localize to internal tubular membrane structures. However, deletion of AQP1 had minimal effects on collagen-induced platelet granule secretion, aggregation, or membrane ballooning. Conversely, procoagulant spreading, microvesiculation, phosphatidylserine exposure, and clot formation time were significantly diminished. Furthermore, in vivo thrombus formation after FeCl3 injury to carotid arteries was also markedly suppressed in AQP1-null mice, but hemostasis after tail bleeding remained normal. The mechanism involves an AQP1-mediated rapid membrane stretching during procoagulant spreading but not ballooning, leading to calcium entry through mechanosensitive cation channels and a full procoagulant response. We conclude that AQP1 is a major regulator of the platelet procoagulant response, able to modulate coagulation after injury or pathologic stimuli without affecting other platelet functional responses or normal hemostasis. Clinically effective AQP1 inhibitors may therefore represent a novel class of antiprocoagulant antithrombotics.

Authors

Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole

×

Figure 6

AQP1 is localized in proximity to mechanosensitive cation channels, and its deletion or mechanosensitive cation channel blockade attenuates extracellular calcium entry, PS exposure, and microvesiculation.

Options: View larger image (or click on image) Download as PowerPoint
AQP1 is localized in proximity to mechanosensitive cation channels, and ...
(A) Human platelets were stained with antibodies against AQP1, TRPC6, and Piezo1, and images were evaluated for colocalization. Pearson’s correlation analysis demonstrates AQP1 to be in proximity to TRPC6 and Piezo1 but not in significant proximity to TRPC1. (B) AQP1 interaction with TRPC6 in human platelets after evaluation by Förster resonance energy transfer (FRET). (C and D) Washed mouse platelets in modified Tyrode supplemented with 1 mM calcium were labeled with the calcium indicator Fluo-4 (green) and Alexa Fluor 568–annexin V (AnxV, red) and allowed to adhere to collagen-coated surfaces. (C and D) Platelets superimposed for AnxV and Fluo-4 at time points after adherence to collagen corresponding to the numbered arrows in the graphs below. Data are for AQP1+/+ (magenta) and AQP1–/– (blue) platelets. Box-and-whisker plots of peak change and area under the curve (AUC_15 min) of calcium responses in untreated platelets (NoTrm) and in platelets pretreated with the cytosolic calcium chelator BAPTA-AM (1 μM), extracellular calcium chelator EGTA (1 mM), and sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin (1 μM) in AQP1+/+ and AQP1–/– platelets. Similarly, the peak change and AUC of annexin V binding were quantified and shown. (E) Mouse platelets were preincubated with the mechanosensitive channel inhibitor Grammostola spatulata mechanotoxin 4 (GsMTx-4) or vehicle as a control; outcome is shown as in C and D. (F) Microvesiculation was quantified in control (untreated) and GsMTx4-treated AQP1+/+ mouse platelets. Data analysis was performed by Wilcoxon signed-rank test. *P < 0.05, **P < 0.01 were considered significant. Scale bar: 1 μm (A and B). Data were from 4 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts